142 related articles for article (PubMed ID: 11887744)
1. [Migraine has to be treated. Otherwise a stroke threatens].
MMW Fortschr Med; 2002 Feb; 144(7):70. PubMed ID: 11887744
[No Abstract] [Full Text] [Related]
2. Electriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan.
Spierings EL
Neurology; 2000 Sep; 55(5):735; author reply 736. PubMed ID: 10980753
[No Abstract] [Full Text] [Related]
3. [Strong and sustained-acting triptan. Therewith migraine does not return soon].
MMW Fortschr Med; 2003 Aug; 145(31-32):53. PubMed ID: 14524078
[No Abstract] [Full Text] [Related]
4. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan.
Al-Shekhlee A; Reed R
Neurology; 2000 Sep; 55(5):735-6. PubMed ID: 11041768
[No Abstract] [Full Text] [Related]
5. Eletriptan (relpax) for migraine.
Med Lett Drugs Ther; 2003 Apr; 45(1155):33-4. PubMed ID: 12719695
[No Abstract] [Full Text] [Related]
6. [New triptanes in control of migraine attacks. More rapid onset of action--more efficient reduction of pain].
MMW Fortschr Med; 2002 Jan; 144(3-4):52-3. PubMed ID: 11862794
[No Abstract] [Full Text] [Related]
7. [New potent serotonin receptor agonist. Helps migraine patients even when other triptans fail].
Einecke D
MMW Fortschr Med; 2001 Jul; 143(26-27):60. PubMed ID: 11481924
[No Abstract] [Full Text] [Related]
8. Musing on Mathew et al.
Kaniecki RG
Headache; 2003 Sep; 43(8):922; author reply 924-8. PubMed ID: 14562838
[No Abstract] [Full Text] [Related]
9. Unilateral time-delayed encapsulation does not make for a fair race.
Loftus BD
Headache; 2003 Sep; 43(8):921; author reply 924-8. PubMed ID: 12940818
[No Abstract] [Full Text] [Related]
10. [Triptans in migraine: from clinical view].
Manaka S
No To Shinkei; 2004 Sep; 56(9):739-45. PubMed ID: 15552862
[No Abstract] [Full Text] [Related]
11. Migraine revolution and sumatriptan.
Palmer JB; Salonen R
Lancet; 2000 Jun; 355(9222):2250-1. PubMed ID: 10881915
[No Abstract] [Full Text] [Related]
12. [Triptans in migraine: a comparative review of pharmacology, pharmacokinetics].
Kato K
No To Shinkei; 2004 Sep; 56(9):733-8. PubMed ID: 15552861
[No Abstract] [Full Text] [Related]
13. [Use of triptanes according to indications. Risk of infarct is not increased].
MMW Fortschr Med; 2004 Feb; 146(7):60. PubMed ID: 15347059
[No Abstract] [Full Text] [Related]
14. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology and efficacy of eletriptan for the treatment of migraine attacks.
Allen C
Int J Clin Pract; 2001 Jun; 55(5):346-7. PubMed ID: 11452689
[No Abstract] [Full Text] [Related]
16. Sumatriptan versus eletriptan: which is best?
Dodick DW
Lancet Neurol; 2002 Dec; 1(8):474. PubMed ID: 12849329
[No Abstract] [Full Text] [Related]
17. [Improved pharmacokinetics. Fast tryptan with sustained response].
MMW Fortschr Med; 2003 May; 145 Suppl 2():106-7. PubMed ID: 14579498
[No Abstract] [Full Text] [Related]
18. [Triptanes in the treatment of migraine. A review based on three Cochrane reviews].
Tfelt-Hansen P; Iversen HK
Ugeskr Laeger; 2006 May; 168(19):1850-3. PubMed ID: 16756800
[No Abstract] [Full Text] [Related]
19. [Highly selective beginning. Associated symptoms and side effects in retrospect].
MMW Fortschr Med; 2003 May; 145 Suppl 2():107. PubMed ID: 14579499
[No Abstract] [Full Text] [Related]
20. Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain--results of a model-based meta-analysis that accounts for encapsulation.
Mandema JW; Cox E; Alderman J
Cephalalgia; 2005 Sep; 25(9):715-25. PubMed ID: 16109054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
